Clinical Trial Update: A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase Ib trial of cibisatamab with atezolizumab after obinutuzumab pretreatment in previously treated metastatic colorectal adenocarcinoma; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Cibisatamab (cibisatamab)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 1 | Status: TERMINATED